Early outcome of children with complex atrial isomerism undergoing uni-ventricular cardiac palliation

Giridhar V Santhanam1, Hani K Najm, Johannes P Duplessis

  • 1Cardiac Science Department, King Abdul-Aziz Medical City, National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.

Saudi Medical Journal
|December 7, 2007
PubMed

Insights

Children with atrial isomerism and complex heart defects undergoing uni-ventricular repair had challenging but comparable outcomes to literature. Early results showed significant morbidity but also successful staged surgical palliation.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Atrial isomerism is a rare condition often associated with complex congenital heart disease (CHD).
  • Management of these complex cardiac defects in children requires specialized surgical approaches, including uni-ventricular repair.

Purpose of the Study:

  • To evaluate the intensive care unit (ICU) course and early outcomes of pediatric patients with atrial isomerism undergoing uni-ventricular heart repair.
  • To assess the challenges and potential risks associated with surgical repair in this patient population.

Main Methods:

  • Retrospective review of pediatric patients with atrial isomerism who underwent uni-ventricular repair between January 2000 and December 2004.
  • Analysis of ICU course, complications, and early surgical outcomes.

Main Results:

  • Ten patients underwent uni-ventricular repair, with an 80% survival rate for the first stage.
  • Complications such as sepsis and prolonged mechanical ventilation occurred in 40% of cases.
  • Over 50% of operated patients experienced prolonged ICU stays (>2 weeks).

Conclusions:

  • Atrial isomerism frequently presents with complex cardiac defects requiring staged surgical repair.
  • Surgical management and peri-operative care for these patients are challenging, carrying risks of morbidity and mortality.
  • Outcomes for children with atrial isomerism undergoing uni-ventricular palliation in this setting were comparable to existing literature.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...